Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Amortization of Deferred Charges (2017 - 2022)

Historic Amortization of Deferred Charges for Inspire Medical Systems (INSP) over the last 6 years, with Q1 2022 value amounting to $62000.0.

  • Inspire Medical Systems' Amortization of Deferred Charges rose 689.66% to $62000.0 in Q1 2022 from the same period last year, while for Mar 2022 it was $244000.0, marking a year-over-year increase of 701.75%. This contributed to the annual value of $240000.0 for FY2021, which is 714.29% up from last year.
  • According to the latest figures from Q1 2022, Inspire Medical Systems' Amortization of Deferred Charges is $62000.0, which was up 689.66% from $62000.0 recorded in Q4 2021.
  • In the past 5 years, Inspire Medical Systems' Amortization of Deferred Charges registered a high of $213000.0 during Q1 2018, and its lowest value of $51000.0 during Q2 2019.
  • Its 5-year average for Amortization of Deferred Charges is $80117.6, with a median of $59000.0 in 2021.
  • In the last 5 years, Inspire Medical Systems' Amortization of Deferred Charges skyrocketed by 24918.03% in 2018 and then crashed by 5952.38% in 2019.
  • Inspire Medical Systems' Amortization of Deferred Charges (Quarter) stood at $112000.0 in 2018, then crashed by 51.79% to $54000.0 in 2019, then rose by 7.41% to $58000.0 in 2020, then rose by 6.9% to $62000.0 in 2021, then changed by 0.0% to $62000.0 in 2022.
  • Its Amortization of Deferred Charges was $62000.0 in Q1 2022, compared to $62000.0 in Q4 2021 and $61000.0 in Q3 2021.